Literature DB >> 8698825

Forced expression of dystrophin deletion constructs reveals structure-function correlations.

J A Rafael1, G A Cox, K Corrado, D Jung, K P Campbell, J S Chamberlain.   

Abstract

Dystrophin plays an important role in skeletal muscle by linking the cytoskeleton and the extracellular matrix. The amino terminus of dystrophin binds to actin and possibly other components of the subsarcolemmal cytoskeleton, while the carboxy terminus associates with a group of integral and peripheral membrane proteins and glycoproteins that are collectively known as the dystrophin-associated protein (DAP) complex. We have generated transgenic/mdx mice expressing "full-length" dystrophin constructs, but with consecutive deletions within the COOH-terminal domains. These mice have enabled analysis of the interaction between dystrophin and members of the DAP complex and the effects that perturbing these associations have on the dystrophic process. Deletions within the cysteine-rich region disrupt the interaction between dystrophin and the DAP complex, leading to a severe dystrophic pathology. These deletions remove the beta-dystroglycan-binding site, which leads to a parallel loss of both beta-dystroglycan and the sarcoglycan complex from the sarcolemma. In contrast, deletion of the alternatively spliced domain and the extreme COOH terminus has no apparent effect on the function of dystrophin when expressed at normal levels. The proteins resulting from these latter two deletions supported formation of a completely normal DAP complex, and their expression was associated with normal muscle morphology in mdx mice. These data indicate that the cysteine-rich domain is critical for functional activity, presumably by mediating a direct interaction with beta-dystroglycan. However, the remainder of the COOH terminus is not required for assembly of the DAP complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698825      PMCID: PMC2120912          DOI: 10.1083/jcb.134.1.93

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  44 in total

Review 1.  The structural and functional diversity of dystrophin.

Authors:  A H Ahn; L M Kunkel
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

2.  Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.

Authors:  B Yang; D Jung; J A Rafael; J S Chamberlain; K P Campbell
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

3.  Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin.

Authors:  A Suzuki; M Yoshida; K Hayashi; Y Mizuno; Y Hagiwara; E Ozawa
Journal:  Eur J Biochem       Date:  1994-03-01

4.  Troponin T is capable of binding dystrophin via a leucine zipper.

Authors:  J A Pearlman; P A Powaser; S J Elledge; C T Caskey
Journal:  FEBS Lett       Date:  1994-11-07       Impact factor: 4.124

5.  Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution.

Authors:  M E Adams; M H Butler; T M Dwyer; M F Peters; A A Murnane; S C Froehner
Journal:  Neuron       Date:  1993-09       Impact factor: 17.173

6.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.

Authors:  G A Cox; S F Phelps; V M Chapman; J S Chamberlain
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

7.  Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin).

Authors:  S L Roberds; R D Anderson; O Ibraghimov-Beskrovnaya; K P Campbell
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

8.  Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.

Authors:  G A Cox; N M Cole; K Matsumura; S F Phelps; S D Hauschka; K P Campbell; J A Faulkner; J S Chamberlain
Journal:  Nature       Date:  1993-08-19       Impact factor: 49.962

9.  Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.

Authors:  J A Rafael; Y Sunada; N M Cole; K P Campbell; J A Faulkner; J S Chamberlain
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

10.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more
  64 in total

1.  The dystrophin-associated glycoprotein complex: what parts can you do without?

Authors:  H L Sweeney; E R Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.

Authors:  B Wang; J Li; X Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

Authors:  Paul Gregorevic; Michael J Blankinship; James M Allen; Robert W Crawford; Leonard Meuse; Daniel G Miller; David W Russell; Jeffrey S Chamberlain
Journal:  Nat Med       Date:  2004-07-25       Impact factor: 53.440

Review 4.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 6.  Challenges for gene therapy for muscular dystrophy.

Authors:  Jerry R Mendell; K Reed Clark
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

7.  Dystrobrevin and dystrophin: an interaction through coiled-coil motifs.

Authors:  H M Sadoulet-Puccio; M Rajala; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

Review 8.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

9.  Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein.

Authors:  Dejia Li; Yongping Yue; Dongsheng Duan
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

10.  The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins.

Authors:  Glen B Banks; Luke M Judge; James M Allen; Jeffrey S Chamberlain
Journal:  PLoS Genet       Date:  2010-05-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.